| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4006010 | American Journal of Ophthalmology | 2006 | 10 Pages |
Abstract
Verteporfin PDT combined with intravitreal triamcinolone may improve the outcome of standard verteporfin PDT in the treatment of occult CNV secondary to AMD. An improvement in visual acuity was observed in most of the treated patients and was maintained during a two-year follow-up period. Retreatment numbers were lower than expected from monotherapy trials.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Albert J. MD, Ursula MD,